PCGF3 and lung carcinoma: In 2021, Chen et al. [87] proved that hsa-miR-210-3p was upregulated in lung cancer tissues, and hsa-miR-210-3p facilitated lung cancer development and metastasis by impairing USF1-mediated promotion of PCGF3.